0-VD | 1-VD | ⩾2-VD | |
---|---|---|---|
Data are mean (SD). | |||
*p<0.05 v 0-VD; †p<0.05 v 1-VD by χ2 test or Kruskal-Wallis test followed by Mann-Whitney U test with Bonferroni correction. | |||
ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin II receptor blockers; BMI, body mass index; DBP, diastolic blood pressure; HbA1c, haemoglobin A1c; HDL-C, high density lipoprotein cholesterol; MI (−), no previous myocardial infarction; MI (+), previous myocardial infarction; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; VD, vessel disease. | |||
Age (years) | 59.4 (9.1) | 62.6 (9.0) | 62.3 (7.6) |
Sex (male/female) | 21/10 | 52/13 | 42/6 |
MI (−) | 29/ | 31/ | 29/ |
MI (+) | 2 | 34* | 19* |
BMI (kg/m2) | 22.9 (2.7) | 23.3 (2.9) | 24.1 (3.0) |
Current smoker | 54.8% | 40.0% | 45.8% |
HbA1c (%) | 5.5 (0.5) | 5.6 (0.4) | 5.4 (0.4) |
TC (mmol/l) | 5.17 (0.91) | 5.34 (0.93) | 5.25 (1.03) |
TG (mmol/l) | 1.64 (1.17) | 1.64 (1.01) | 1.54 (0.64) |
HDL-C (mmol/l) | 1.37 (0.39) | 1.28 (0.32) | 1.14 (0.28)*† |
SBP (mm Hg) | 132.4 (14.6) | 133.9 (26.8) | 133.5 (19.0) |
DBP (mm Hg) | 74.5 (10.5) | 73.7 (16.4) | 77.6 (11.2) |
Medications | |||
Calcium channel blockers | 96.8% | 56.3%* | 70.8%* |
β Adrenergic blockers | 0% | 60.0%* | 62.5%* |
ACEI/ARB | 6.5% | 48.4%* | 47.9%* |
Diuretics | 0% | 1.6% | 10.4%*† |
Lipid lowering agents | 35.5% | 56.3% | 54.2% |